Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women
- 11 November 2022
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 74 (10) , 948-957
Abstract
Endocan, or endothelial cell-specific molecule-1 (ESM-1), is a potential inflammatory marker implicated in endothelial dysfunction. The purpose of this study was to determine the correlation between serum endocan levels and the presence and severity of endothelial dysfunction, and the relationships with serum intracellular adhesion molecule-1 (ICAM-1), adiponectin (a marker of inflammation), high sensitivity C-reactive protein (hsCRP) levels, and carotid intima-media thickness (cIMT) in obese subjects. Serum endocan, ICAM-1, adiponectin, hsCRP levels, and cIMT were evaluated in 76 obese women (BMI > 30 kg/m 2 ) and 53 controls (BMI < 25 kg/m 2 ). ICAM-1 ( P = .01), hs-CRP (p < 0.001), and cIMT ( p < .001) were significantly higher, while adiponectin ( P = .006) was significantly lower, in obese women compared with the controls. Serum endocan levels were similar between the obese (470.5 ± 171.3 pg/mL) and controls (471.9 ± 146.3 pg/mL) ( P = .732). There was no correlation between serum endocan values and the endothelial dysfunction markers, hsCRP (r = −.021), ICAM-1 (r = −.054), adiponectin (r = .113), or cIMT (r = −.060) in obesity. Endocan is not a suitable marker of endothelial dysfunction in the context of obesity. More research is required to evaluate the role of endocan in the regulation of inflammatory processes in obesity.Keywords
Funding Information
- Recep Tayyip Erdogan Üniversitesi (2015.53002.106.03.01)
This publication has 51 references indexed in Scilit:
- The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)Journal of Human Hypertension, 2010
- The levels of the leptin and adiponectin according to body mass index and their relationship with oxidative parametersAnadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2010
- Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycanGlycobiology, 2010
- The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic ConsequencesClinical Chemistry, 2008
- Endothelial dysfunction and arterial abnormalities in childhood obesityInternational Journal of Obesity, 2006
- Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- ObesityThe Lancet, 2005
- Characterization of the Secreted Form of Endothelial-Cell-Specific Molecule 1 by Specific Monoclonal AntibodiesJournal of Vascular Research, 2000
- Reproducibility of In Vivo Carotid Intima-Media Thickness MeasurementsStroke, 1997
- Increased risk for type I (insulin‐dependent) diabetes in relatives of patients with alopecia areata (AA)American Journal of Medical Genetics, 1994